[22] [23] Other digestive symptoms may include mild abdominal discomfort, occasional vomiting, or changes in bowel habits (either constipation or loose stools)
If youve spent any time researching semaglutide, tirzepatide, or retatrutide, youve probably come across the word agonist more times than you can count
Retatrutide is still in clinical development
See CoA for purity data
BSH, bile salt hydrolase
Glucagon-like peptide-1 (GLP-1) receptor agonists are a family of antihyperglycemic drugs that have demonstrated potent HbA1c reduction, low risk of hypoglycemia, with associated weight reduction, and proven cardiovascular and renal benefits.24 In this review we describe this type of drugs, their cardiovascular and renal benefits, as well as their clinical potential in patients with DKD, especially with the new oral semaglutide formulation, now available on the market